The Biotechnology Industry Organization and Critical Path Institute Partner With Mediaplanet, Biocom, and the University of California Office to Spotlight the Science That Is Healing, Fueling and Feeding Our Global Population

LOS ANGELES, Dec. 9, 2010 /PRNewswire/ -- On Thursday, December 9th, Mediaplanet published one of the largest consumer reports on biotechnology, spearheading an industry-wide call to action advocating consumer support of biotechnology, the science that is helping us confront society's most pressing challenges. By teaming up with the world's largest biotechnology organization, Mediaplanet's 'Biotechnology' encourages appropriate policy action and investment in the science that is healing, fueling and feeding our future. Biotechnology is the medical discovery that saves millions of lives, the agricultural innovation that fends off impending world hunger and the solution to ever-rising crude oil prices. The crucial idea—that investment in biotechnology is an investment in our future and in essence, in ourselves—is the idea this report aims to bring home.

(Logo:  http://photos.prnewswire.com/prnh/20100820/CG52983LOGO)

Rolf Benirschke Dedicates Life After Ulcerative Colitis to Biomedical Advancements

"I've been a beneficiary of modern science based on research," explains former San Diego Charger and NFL Great, Rolf Benirschke, on his struggle with ulcerative colitis, and the blood transfusion that both saved his life and gave him Hepatitis C. Son of a world-renowned pathologist, Benirschke finds himself in the medical field dealing with biotechnology advancements on a daily basis.

No on Proposition 23: California Biofuels Industry Poised for Growth

During the November elections, Proposition 23 was defeated by California voters—California is poised to take the lead in clean and renewable energy, with emerging solutions like algae based biofuels, and large-scale production of advanced biofuels.

James C. Greenwood Explains Regulatory Approval Process for Biosimilars

An important provision of healthcare reform established a regulatory approval process for biosimilars, medicines that are similar to pioneering biologics. BIO encourages the FDA to make patient safety the priority, while preserving necessary incentives to develop new breakthrough therapies.

Mediaplanet's Report:

With the help of the Biotechnology Industry Organization, Critical Path Institute, Biocom, the University of California Office of the President, Algenol, Amgen, Byogy, EquipNet, and Syngenta, Mediaplanet published one of the largest distributed Biotechnology report in US history.

To view this report CLICK HERE or click the link below: http://www.latimesinteractive.com/advertising/mediaplanet/biotechnology/images/LaT%20Biotechnology%20FINAL%20smO.PDF

Mediaplanet creates focused reports on business, healthcare and technology.

For more information go to www.mediaplanet.com or call 312-337-4000.

SOURCE Mediaplanet